top_10_image_2_1

Top Ten most popular articles on Pharmafile.com this week

pharmafile | July 24, 2020 | News story | Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, coronavirus, top 10, top 10 stories 

As the coronavirus pandemic shows no signs of slowing down, an Israeli doctor has appeared to have contracted COVID-19 for a second time after they tested positive for the virus 3 months after recovering from it, while health officials in Switzerland are warning against wearing plastic face shields without masks after a recent outbreak at a hotel showed them to be ineffective.

In non-coronavirus related news, the FDA has released their guidelines on the rules companies should follow when developing cannabis derived drugs.

1. Israeli doctor tests positive for coronavirus 3 months after recovering

An Israeli doctor has appeared to have contracted COVID-19 for a second time after they tested positive for the virus 3 months after recovering from it.

2. UK secures early access to 90 million doses of coronavirus vaccines

The UK has secured early access to 90 million doses of coronavirus vaccines through multiple partnerships with pharmaceutical companies.

3. Synairgen drug doubles likelihood of recovery in hospitalised COVID-19 patients, early data show

Respiratory drug firm Synairgen has, like many, been hard at work on a treatment for patients with COVID-19; the company has just revealed promising data on the interferon beta-based therapy, known as SNG001, in the treatment of patients hospitalised with the disease.

4. Face shields did not protect people from a COVID-19 outbreak in Switzerland but masks did, according to health officials

Health officials in Switzerland are warning against wearing plastic face shields without masks after a recent outbreak at a hotel showed them to be ineffective.

5. Mylan launches generic version of Gilead’s remdesivir for COVID-19 patients in India

Mylan has launched its own generic version of Gilead’s remdesivir on the Indian market for the treatment of patients with COVID-19 under the brand name Desrem, it has emerged.

6. Hydroxychloroquine proves ineffective against COVID-19 in newest trial

The newest clinical trial into hydroxychloroquine has proved unsuccessful in treating coronavirus patients.

7. Fujifilm to begin clinical trials testing Avigan in COVID-19 patients in Kuwait

Fujifilm will begin clinical trials investigating the effectiveness of Avigan in treating coronavirus patients in Kuwait.

8. FDA sets out guidelines on cannabis derived drugs

The FDA has released their guidelines on the rules companies should follow when developing cannabis derived drugs.

 

9. Study launched to assess if asthma treatment ciclesonide can treat COVID-19
Researchers at the University of Buffalo have launched a study to see if the steroid treatment ciclesonide could be effective in treating the coronavirus.

9. Study launched to assess if asthma treatment ciclesonide can treat COVID-19

Researchers at the University of Buffalo have launched a study to see if the steroid treatment ciclesonide could be effective in treating the coronavirus.

10. British pandemic strategy has been an “astonishing” failure, says cross-party parliamentary committee

There was an “astonishing” failure of the British government to plan for the economic fallout of a potential pandemic, according to a cross-party group of MPs.

 

Conor Kavanagh

Related Content

FDA approves first oral antiviral to treat adult patients with COVID-19

The US Food and Drug Administration (FDA) has announced that it has approved the oral …

moderna_norwood_plant

Moderna and Pfizer COVID-19 vaccine protection declines over time

Data presented by Pfizer and Moderna ahead of the FDA’s vaccine advisory committee meeting on …

Sanofi complete acquisition of mRNA company Translate Bio

French pharma giants Sanofi continues its run of acquisitions in 2021 by completing the deal …

Latest content